One-step mechanochemical preparation and prominent antitumor activity of SN-38 self-micelle solid dispersion

References

• JaxelCKohnKWWaniMCWallMEPommierYStructure-activity study of the actions of camptothecin derivatives on mammalian topoisomerase I: evidence for a specific receptor site and a relation to antitumor activityCancer Res1989496146514692538227
   PubMed Web of Science ®Google Scholar
• BisseryMCVrignaudPLavelleFChabotGGExperimental antitumor activity and pharmacokinetics of the camptothecin analog irinotecan (CPT-11) in miceAnticancer Drugs1996744374608826613
   PubMedGoogle Scholar
• SlatterJGSuPSamsJPSchaafLJWienkersLCBioactivation of the anticancer agent CPT-11 to SN-38 by human hepatic microsomal carboxylesterases and the in vitro assessment of potential drug interactionsDrug Metab Dispos19972510115711649321519
   PubMed Web of Science ®Google Scholar
• IyerLHallDDasSPhenotype-genotype correlation of in vitro SN-38 (active metabolite of irinotecan) and bilirubin glucuronidation in human liver tissue with UGT1A1 promoter polymorphismClin Pharmacol Ther199965557658210340924
   PubMed Web of Science ®Google Scholar
• IyerLKingCDWhitingtonPFGenetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomesJ Clin Invest199810148478549466980
   PubMed Web of Science ®Google Scholar
• ZhangJAXuanTParmarMDevelopment and characterization of a novel liposome-based formulation of SN-38Int J Pharm20042701–29310714726126
   PubMed Web of Science ®Google Scholar
• RogerELagarceFBenoitJPDevelopment and characterization of a novel lipid nanocapsule formulation of SN38 for oral administrationEur J Pharm Biopharm201179118118821303693
   PubMed Web of Science ®Google Scholar
• SapraPZhaoHMehligMNovel delivery of SN38 markedly inhibits tumor growth in xenografts, including a camptothecin-11-refractory modelClin Cancer Res20081461888189618347192
   PubMed Web of Science ®Google Scholar
• YellepeddiVKVangaraKKPalakurthiSIn vivo efficacy of PAMAM-Dendrimer-Cisplatin complexes in SKOV-3 xenografted BALB/c nude miceJ Biotechnol Biomater213003
   Google Scholar
• VangaraKKLiuJLPalakurthiSHyaluronic acid-decorated PLGA-PEG nanoparticles for targeted delivery of SN-38 to ovarian cancerAnticancer Res20133362425243423749891
   PubMed Web of Science ®Google Scholar
• SadzukaYTakabeHSonobeTLiposomalization of SN-38 as active metabolite of CPT-11J Control Release20051082–345345916182400
   PubMed Web of Science ®Google Scholar
• GuQXingJZHuangMHeCChenJSN-38 loaded polymeric micelles to enhance cancer therapyNanotechnology2012232020510122543761
   PubMed Web of Science ®Google Scholar
• CarieARios-DoriaJCostichTIT-141, a polymer micelle encapsulating SN-38, induces tumor regression in multiple colorectal cancer modelsJ Drug Deliv201120111–219
   Google Scholar
• ZhaoHRubioBSapraPNovel prodrugs of SN38 using multiarm poly(ethylene glycol) linkersBioconjug Chem200819484985918370417
   PubMed Web of Science ®Google Scholar
• KurzrockRGoelSWhelerJSafety, pharmacokinetics, and activity of EZN-2208, a novel conjugate of polyethylene glycol and SN38, in patients with advanced malignanciesCancer2012118246144615122674635
   PubMed Web of Science ®Google Scholar
• Meyer-LosicFNicolazziCQuinoneroJDTS-108, a novel peptidic prodrug of SN38: in vivo efficacy and toxicokinetic studiesClin Cancer Res20081472145215318381956
   PubMed Web of Science ®Google Scholar
• SerafinoAZonfrilloMAndreolaFCD44-targeting for antitumor drug delivery: a new SN-38-hyaluronan bioconjugate for locoregional treatment of peritoneal carcinomatosisCurr Cancer Drug Targets201111557258521486216
   PubMed Web of Science ®Google Scholar
• SuXWuLHuMGlycyrrhizic acid: a promising carrier material for anticancer therapyBiomed Pharmacother20179567067828886526
   PubMed Web of Science ®Google Scholar
• TsaiYMChienCFLinLCTsaiTHCurcumin and its nano-formulation: the kinetics of tissue distribution and blood-brain barrier penetrationInt J Pharm2011416133133821729743
   PubMed Web of Science ®Google Scholar
• PolyakovNELeshinaTVGlycyrrhizic acid as a novel drug delivery vector: synergy of drug transport and efficacyOpen Conf Proc J2011216472
   Google Scholar
• PiperJTSinghalSSSalamehMSMechanisms of anticarcinogenic properties of curcumin: the effect of curcumin on glutathione linked detoxification enzymes in rat liverInt J Biochem Cell Biol19983044454569675878
   PubMed Web of Science ®Google Scholar
• VangaraKKAliHILuDSN-38-cyclodextrin complexation and its influence on the solubility, stability, and in vitro anticancer activity against ovarian cancerAAPS PharmSciTech201415247248224477982
   PubMed Web of Science ®Google Scholar
• LiuHWangYWangMXiaoJChengYFluorinated poly (propylenimine) dendrimers as gene vectorsBiomaterials201435205407541324709522
   PubMed Web of Science ®Google Scholar
• YellepeddiVKVangaraKKKumarAPalakurthiSComparative evaluation of small-molecule chemosensitizers in reversal of cisplatin resistance in ovarian cancer cellsAnticancer Res20123293651365822993302
   PubMed Web of Science ®Google Scholar
• KumarAYellepeddiVKVangaraKKStrycharKBPalakurthiSMechanism of gene transfection by polyamidoamine (PAMAM) dendrimers modified with ornithine residuesJ Drug Target201119977078021457075
   PubMed Web of Science ®Google Scholar
• JwalaJBodduSHSShahSOcular sustained release nanoparticles containing stereoisomeric dipeptide prodrugs of acyclovirJ Ocul Pharmacol Ther201127216317221500985
   PubMed Web of Science ®Google Scholar
• MamotCDrummondDCNobleCOEpidermal growth factor receptor–targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivoCancer Res20056524116311163816357174
   PubMed Web of Science ®Google Scholar
• ZhangHHollisCPZhangQLiTPreparation and antitumor study of camptothecin nanocrystalsInt J Pharm20114151–229330021679755
   PubMedGoogle Scholar
• Landesman-MiloDRamishettiSPeerDNanomedicine as an emerging platform for metastatic lung cancer therapyCancer Metastasis Rev201534229130125948376
   PubMedGoogle Scholar
• YoshiokaKSakaiEDaimonMKitaharaARole of steric hindrance in the performance of Superplasticizers for ConcreteJ Am Ceram Soc1997801026672671
   Web of Science ®Google Scholar
• BalaVRaoSBoydBJPrestidgeCAProdrug and nanomedicine approaches for the delivery of the camptothecin analogue SN38J Control Release20131721486123928356
   PubMed Web of Science ®Google Scholar
• TangXJHanMYangBNanocarrier improves the bioavailability, stability and antitumor activity of camptothecinInt J Pharm20144771–253654525445532
   PubMed Web of Science ®Google Scholar
• ChuCAbbaraCTandiaMCetuximab increases concentrations of irinotecan and of its active metabolite SN-38 in plasma and tumour of human colorectal carcinoma-bearing miceFundam Clin Pharmacol201428665266024588516
   PubMedGoogle Scholar
• des RieuxAFievezVGarinotMSchneiderYJPréatVNanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approachJ Control Release2006116112717050027
   PubMed Web of Science ®Google Scholar
• VeberDFJohnsonSRChengHYMolecular properties that influence the oral bioavailability of drug candidatesJ Med Chem200245122615262312036371
   PubMed Web of Science ®Google Scholar
• PolyakovNEKispertLDWater soluble biocompatible vesicles based on polysaccharides and oligosaccharides inclusion complexes for carotenoid deliveryCarbohydr Polym201512820721926005157
   PubMed Web of Science ®Google Scholar